February 21, 2023
Evusheld (tixagevimab/cilgavimab), an antibody combination of AstraZeneca used to prevent COVID-19, has received a label update to add information on repeat dosing. For the second or later administration of the drug, the label recommends a repeat dose interval of six...read more